cholestyramine resin has been researched along with Acquired Immune Deficiency Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finkelstein, MO; Levin, B; Robbins, H | 1 |
| Kain, ZN; Shapiro, WL | 1 |
2 other study(ies) available for cholestyramine resin and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Clinical and prophylactic trials with assured new treatment for those at greater risk: II. Examples.
Topics: Acquired Immunodeficiency Syndrome; Cholesterol; Cholestyramine Resin; Controlled Clinical Trials as Topic; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Humans; Male; Models, Statistical; Patient Selection; Randomized Controlled Trials as Topic; Regression Analysis; Research Design; Risk Factors; Survival Analysis; Zidovudine | 1996 |
Diarrhea in infants with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Cholestyramine Resin; Diarrhea; Gentamicins; Humans; Infant | 1988 |